Bespoke Extracts (BSPK) Interest Coverage Ratio (QoQ) (2016 - 2025)
Bespoke Extracts (BSPK) Interest Coverage Ratio (QoQ) (2016 - 2025) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn |
| 10 | Bespoke Extracts | 1.12 Mn | 1.11 Mn | 234,175.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 6.49% |
| Jun 30, 2025 | 22.34% |
| Mar 31, 2025 | -178.07% |
| Dec 31, 2024 | 94.48% |
| Sep 30, 2024 | 15.01% |
| Jun 30, 2024 | 12.21% |
| Mar 31, 2024 | 57.85% |
| Dec 31, 2023 | -1,601.35% |
| Sep 30, 2023 | 69.83% |
| Jun 30, 2023 | -121.43% |
| Mar 31, 2023 | -161.45% |
| Dec 31, 2022 | 87.23% |
| Sep 30, 2022 | -432.12% |
| Jun 30, 2022 | 75.45% |
| May 31, 2020 | -1,051.69% |
| Feb 29, 2020 | 94.84% |
| Nov 30, 2019 | 99.99% |
| Aug 31, 2019 | -12,351,659.36% |
| May 31, 2019 | -6.78% |
| Feb 28, 2019 | -105.06% |